I can give you a specific answer with respect to Quebec by way of the example of one medication, Avastin. We know that Avastin has federal approval, so the safety requirements have been met and it is available. Two provinces fund it: British Columbia and Newfoundland. In Quebec, although it forms part of the treatment guidelines for colorectal cancer, and those were set in Quebec, unfortunately, only one hospital is paying for this drug out of its hospital budget.
So having something within the treatment guidelines is not necessarily a guarantee that it will be offered to the public, and that's something, of course, that we're addressing in Quebec. Guidelines are very important, but they don't necessarily guarantee that it will be reimbursed.